Page last updated: 2024-10-23

azathioprine and Lymphangioleiomyomatosis

azathioprine has been researched along with Lymphangioleiomyomatosis in 1 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Lymphangioleiomyomatosis: A disease characterized by the progressive invasion of SMOOTH MUSCLE CELLS into the LYMPHATIC VESSELS, and the BLOOD VESSELS. The majority of the cases occur in the LUNGS of women of child-bearing age, eventually blocking the flow of air, blood, and lymph. The common symptom is shortness of breath (DYSPNEA).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
González, LA1
Pantoja-Marquez, AE1
Johnson, P1

Other Studies

1 other study available for azathioprine and Lymphangioleiomyomatosis

ArticleYear
Diffuse Cystic Lung Disease: Consider Sjögren Syndrome in the Differential Diagnosis.
    The American journal of medicine, 2020, Volume: 133, Issue:8

    Topics: Adult; Antibodies, Antinuclear; Antirheumatic Agents; Azathioprine; Cysts; Diagnosis, Differential;

2020